Replies to post #642067 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Note 2: NWBO’s valuation has nothing to do with Advent’s valuation. However, Advent’s valuation has almost everything to do with the valuation of NWBO based on the success of the RA approvals.

Yes Advent depends on that one big client NWBO for its revenue and thus valuation. However, if it needs to be. There is a massive amount of work for a CDMO such as Advent out there and a pivot to other big clients can be made within months. The value of Advent is most and foremost in its staff, the MIA certificate, and their overall high quality in knowledge and process of cell therapy production, not just revenue.

[norisknorewards]

Wolf pack leader,

How goes your litigation in Florida?